iGEM 2005: Synthetic Biology’s Future


By John Russell Bio-IT World

Cambridge, Mass. – Before plunging too deeply into iGEM 2005 – the intercollegiate Genetically Engineered Machine competition, held at MIT last weekend, consider a few of the awards: Best Use of Transmogrified Smiley Faces (Caltech), Best Confession (U Texas), Most Modest Goal (MIT), Best Uniform (University of Cambridge, U.K.) My favorite was Best “Hail Mary” Cloning (Oklahoma).

Teams from 13 colleges, comprised mostly of undergraduates, worked over the summer towards the not-so-modest goal of “designing and building the ‘coolest’ systems from standard, interchangeable biological parts and to operate those systems in living cells.” There were digital decoders, light-controlled gene expression techniques, bacterial relay races, a bacterial sketch pad, and of course, transmogrified smiley faces. Students used genetic engineering to coax bacteria to perform a wide variety of tasks.

 

2005 iGEM
Teams:

 
 

Princeton
Oklahoma
ETH Zurich
MIT
Caltech
U. Toronto
U Cambridge
Texas U
Penn State
UC Berkeley
Davidson
Harvard
UCSF

 
That many projects didn’t work quite as planned misses the point, explains iGEM coordinator Randy Rettberg, a principal research engineer in biological engineering division at MIT and director of the Registry of Standard Biological Parts at MIT. Following presentations by all the teams on Saturday, Rettberg told the young bioengineers, “Without your optimism, you’d be stopped early.” 

These students, suggests Rettberg, are internalizing the notion that biology can be marshaled to perform almost anything that mechanical or electronic systems can do. They are also building the parts to tackle those tasks. “Most of the parts in the registry have been contributed by students,” he says.

Rettberg is staunch evangelist for synthetic biology, and came to MIT by a somewhat circuitous route. An engineer by training, he worked for years at Internet pioneer BBN (now Genuity), later moved to Sun Microsystems, where he was CTO for storage systems, and came to MIT just a few years ago.

“I believe learning something brand new is entirely refreshing,” says Rettberg. Encouraged by prominent MIT researcher Tom Knight, Rettberg dove into biology and bioengineering. He has big hopes for iGEM.

Last year, just five schools – MIT, Caltech, Boston University (with participation from Harvard), Princeton, and the University of Texas, Austin, competed. Response mushroomed this year. “Fifty students applied for the University of Cambridge team of six. I count that as 44 disappointed students,” he says.

Indeed, rather than rank winners hierarchically, Rettberg and the other judges made 50 or so awards. Student teams worked on their projects throughout the summer, and several are continuing in efforts to complete their projects. Next year Rettberg expects 30 to 50 schools to compete and he’s scanning the horizon for funding sources.

Related links:

iGEM

Synthetic Biology: The Real Thing

Real Promise for Synthetic Biology

It's a Bug's Life

 

  

 

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.